Get the latest updates on U.S. startups securing Series C to IPO funding, featuring key deals, top investors, and emerging industries shaping the future.
All content for The Growth Investor Daily Brief is the property of PodcastAI and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Get the latest updates on U.S. startups securing Series C to IPO funding, featuring key deals, top investors, and emerging industries shaping the future.
OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans
The Growth Investor Daily Brief
5 minutes 59 seconds
11 months ago
OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans
Michelle welcomes listeners to the latest episode of The Growth Investor Daily Brief, diving into recent Series C+ funding updates. The episode covers OneRail's efforts in optimizing last-mile delivery and their funding plans, as well as Tenstorrent's Series D success in the AI chip sector. Additionally, Maze Therapeutics' Series D financing and their future strategic plans are discussed. The episode wraps up with investor insights, providing listeners with essential information to stay informed about the evolving investment landscape.
The Growth Investor Daily Brief
Get the latest updates on U.S. startups securing Series C to IPO funding, featuring key deals, top investors, and emerging industries shaping the future.
